Skip to main content
In-vitro Diagnostics Instruments Market Analysis, Size, and Forecast 2026-2030: North America (US, Canada, and Mexico), Europe (Germany, UK, and France), Asia (China, Japan, and India), South America (Brazil, Argentina, and Colombia), Middle East and Africa (Saudi Arabia, UAE, and Turkey), Rest of World (ROW)

In-vitro Diagnostics Instruments Market Analysis, Size, and Forecast 2026-2030:
North America (US, Canada, and Mexico), Europe (Germany, UK, and France), Asia (China, Japan, and India), South America (Brazil, Argentina, and Colombia), Middle East and Africa (Saudi Arabia, UAE, and Turkey), Rest of World (ROW)

Published: Oct 2026 320 Pages SKU: IRTNTR71190

Market Overview at a Glance

$67.72 B
Market Opportunity
10%
CAGR 2025 - 2030
31.9%
Asia Growth
$43.08 B
Immunochemistry segment 2024

In-Vitro Diagnostics Instruments Market Size 2026-2030

The in-vitro diagnostics instruments market size is valued to increase by USD 67.72 billion, at a CAGR of 10% from 2025 to 2030. Rising prevalence of chronic and infectious diseases globally will drive the in-vitro diagnostics instruments market.

Major Market Trends & Insights

  • Asia dominated the market and accounted for a 31.9% growth during the forecast period.
  • By Product - Immunochemistry segment was valued at USD 43.08 billion in 2024
  • By End-user - Hospitals and diagnostic laboratories segment accounted for the largest market revenue share in 2024

Market Size & Forecast

  • Market Opportunities: USD 102.91 billion
  • Market Future Opportunities: USD 67.72 billion
  • CAGR from 2025 to 2030 : 10%

Market Summary

  • The In-vitro Diagnostics Instruments landscape is experiencing a profound operational transformation driven by the integration of high-precision diagnostic hardware into decentralized patient care environments. Medical facilities are continuously migrating toward automated systems to manage escalating biological sample volumes efficiently.
  • In real-world clinical operations, the deployment of microfluidic biosensors within emergency triage units allows practitioners to rapidly quantify cardiac biomarkers without waiting on centralized laboratory processing. This structural shift has reduced critical patient diagnostic wait times by 40% compared to traditional batch-testing methodologies.
  • The escalating prevalence of chronic oncology and metabolic disorders acts as a primary catalyst, compelling hospital networks to procure advanced platforms capable of complex liquid biopsy extraction. Conversely, the market faces intense operational friction due to severe shortages of certified medical technologists and increasingly rigorous regulatory validation requirements.
  • Navigating these compliance pathways requires substantial capital investment, limiting the agility of instrument development cycles. Despite these challenges, the continuous adoption of digital pathology algorithms ensures that diagnostic accuracy remains highly standardized across expanding healthcare networks.

What will be the Size of the In-Vitro Diagnostics Instruments Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Get Free Sample

How is the In-Vitro Diagnostics Instruments Market Segmented?

The in-vitro diagnostics instruments industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2026-2030, as well as historical data from 2020-2024 for the following segments.

  • Product
    • Immunochemistry
    • Clinical microbiology
    • Molecular diagnostics
    • Others
  • End-user
    • Hospitals and diagnostic laboratories
    • Academic and research institutes
    • Home care
  • Application
    • Infectious diseases
    • Oncology
    • Diabetes
    • Cardiology
    • Others
  • Geography
    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • The Netherlands
    • Asia
      • China
      • Japan
      • India
      • South Korea
      • Indonesia
      • Thailand
    • Rest of World (ROW)

By Product Insights

The immunochemistry segment is estimated to witness significant growth during the forecast period.

The immunochemistry segment operates as a foundational element within In-vitro Diagnostics Instruments workflows, facilitating highly specific antigen-antibody evaluations. Clinical environments are rapidly transitioning toward advanced chemiluminescence immunoassay platforms that deliver superior sensitivity and dynamic range capabilities.

This structural shift allows medical facilities to execute complex multiplex polymerase chain reaction testing on single, low-volume specimens. By integrating laboratory automation track systems and robotic sample handling, independent diagnostic hubs experience optimized workflow scalability and reduced manual intervention.

Modern instruments now frequently incorporate predictive maintenance software, which has improved continuous operational uptime by 15% across centralized testing networks. Furthermore, enhanced electronic health record interoperability ensures seamless data transmission from diagnostic hardware directly to patient management databases.

This connectivity ultimately stabilizes clinical output and secures long-term closed-system reagent architecture by maintaining consistent performance.

Get Free Sample

The Immunochemistry segment was valued at USD 43.08 billion in 2024 and showed a gradual increase during the forecast period.

Get Free Sample

Regional Analysis

Asia is estimated to contribute 31.9% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

See How In-Vitro Diagnostics Instruments Market Demand is Rising in Asia Get Free Sample

Regional dynamics within the In-vitro Diagnostics Instruments environment reveal stark contrasts in technological adoption and infrastructural readiness between North America and Asia.

North America maintains a heavily consolidated laboratory network, where the integration of automated clinical chemistry lines has increased overall testing throughput by 35% compared to decentralized models in emerging territories.

Facilities in the United States prioritize advanced flow cytometry cell sorting and mass spectrometry pathogen identification to support complex oncology and infectious disease profiling.

Conversely, Asia demonstrates rapid infrastructural expansion, driven by massive public health investments that have boosted the deployment of modular nucleic acid extraction platforms by 42% across regional hospitals.

While North American supply chains focus on maintaining predictive maintenance software for legacy installations, Asian procurement strategies emphasize cost-effective, scalable capillary electrophoresis instruments to bridge rural accessibility gaps.

These differing operational priorities force instrument manufacturers to customize their engineering approaches, balancing premium automation features in mature sectors against ruggedized durability requirements in rapidly expanding healthcare economies.

Market Dynamics

Our researchers analyzed the data with 2025 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

  • The structural modernization of the In-vitro Diagnostics Instruments sector is profoundly altering how healthcare institutions manage acute and chronic patient populations. Clinical laboratories are heavily investing in targeted genomic profiling companion diagnostics to align precise therapeutic interventions with distinct genetic mutations, optimizing expensive pharmaceutical allocations.
  • Simultaneously, emergency medical departments are overhauling their triage protocols by integrating high-sensitivity cardiac troponin testing directly at the bedside. This operational pivot allows physicians to execute rapid cardiovascular risk stratification, decreasing unnecessary hospital admissions by nearly 20% compared to facilities relying solely on off-site reference laboratories.
  • To further expedite localized decision-making, outpatient clinics and remote community centers are deploying rapid point-of-care lateral flow readers that deliver actionable infectious disease data within minutes. In parallel, managing the global diabetes epidemic has accelerated the procurement of continuous metabolic glucose monitoring systems, enabling patients to transmit real-time glycemic data to telehealth platforms for proactive dietary and dosing adjustments.
  • Behind the scenes in microbiology departments, the shift toward automated microbial growth kinetic monitoring has revolutionized pathogen identification timelines. By replacing manual culture reviews with constant digital surveillance, laboratory managers can significantly streamline their supply chain for antimicrobial reagents, ensuring that critical antibiotic stewardship programs operate with maximum clinical efficacy and minimized inventory waste.

What are the key market drivers leading to the rise in the adoption of In-Vitro Diagnostics Instruments Industry?

  • The escalating global prevalence of chronic and infectious diseases functions as a primary catalyst, necessitating higher testing volumes and advanced analytical infrastructure.

  • The escalating demand for In-vitro Diagnostics Instruments is heavily propelled by the structural transition toward decentralized healthcare and precision medicine applications. Clinical networks are continuously striving to maximize diagnostic throughput while minimizing intensive manual labor requirements.
  • Advanced instruments leveraging robust biosensor stability optimization enable remote clinics to perform highly complex assays in varied environmental conditions without degrading analytical reliability.
  • Additionally, the implementation of algorithmic sample identification has streamlined centralized laboratory processing, cutting specimen routing errors by 22% and improving overall workflow efficiency by 16%.
  • This operational stability directly supports seamless tele-health diagnostic integration, allowing real-time transmission of patient data to remote specialists. Furthermore, continuous enhancements in genomic profiling accuracy require institutions to adopt specialized platforms like next-generation sequencing utilizing a closed-system reagent architecture.
  • This guarantees exceptional testing consistency and secures long-term consumable supply chains.

What are the market trends shaping the In-Vitro Diagnostics Instruments Industry?

  • An accelerated transition toward total laboratory automation and artificial intelligence integration represents a structural trend reshaping clinical workflows. This technological evolution significantly reduces analytical turnaround times while optimizing diagnostic accuracy.

  • The architectural evolution of In-vitro Diagnostics Instruments is characterized by a rapid transition toward fully integrated digital ecosystems and decentralized diagnostic hardware. Modern medical facilities are abandoning fragmented standalone analyzers, adopting intelligent platforms that utilize advanced digital data management to streamline complex translational medicine workflows.
  • By optimizing microfluidic cassette architectures, instrument manufacturers have successfully miniaturized critical testing parameters without compromising analytical specificity. This hardware innovation has allowed decentralized clinics to generate metrologically traceable measurements directly at the patient bedside. Consequently, immediate therapeutic decision-making has accelerated, reducing average patient diagnostic wait times by 35%.
  • Furthermore, the incorporation of automated quality control verification algorithms and continuous electrochemical sensor calibration directly into instrument software eliminates the need for manual calibration routines. This intelligent integration decreases system operational downtime by 20% and significantly mitigates pre-analytical errors.
  • These technological shifts are compelling laboratory administrators to restructure long-term procurement strategies, heavily prioritizing equipment that offers seamless connectivity and robust, self-optimizing diagnostic capabilities.

What challenges does the In-Vitro Diagnostics Instruments Industry face during its growth?

  • Stringent and continuously evolving regulatory compliance frameworks impose substantial administrative and financial burdens, thereby protracting product development and market entry cycles.

  • Expanding the operational footprint of In-vitro Diagnostics Instruments is severely constrained by acute shortages of skilled laboratory personnel and increasingly complex regulatory compliance mandates. Modern clinical facilities struggle to achieve optimal diagnostic workflow scalability when confronted with a contracting workforce incapable of operating highly sophisticated analytical hardware.
  • For instance, the deployment of advanced microbial identification systems and intricate optical detection technologies requires extensive technical training to ensure precise calibration and maintenance. When specialized technicians are unavailable, laboratories experience a 25% increase in operational downtime and a 15% reduction in overall testing throughput for routine panels like glycated hemoglobin quantification.
  • Furthermore, stringent validation requirements for life-saving tests, such as rapid cardiac biomarker assays, significantly protract new product development cycles. These regulatory hurdles inflate manufacturing overhead and delay the commercialization of vital diagnostic innovations.

Exclusive Technavio Analysis on Customer Landscape

The in-vitro diagnostics instruments market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the in-vitro diagnostics instruments market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Customer Landscape of In-Vitro Diagnostics Instruments Industry

Competitive Landscape

Companies are implementing various strategies, such as strategic alliances, in-vitro diagnostics instruments market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

Abbott Laboratories - The entity provides comprehensive in-vitro diagnostics instruments designed to optimize clinical laboratory workflows, enhance diagnostic precision, and support scalable testing capabilities across diverse healthcare environments.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Beckman Coulter Inc.
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • BioMerieux SA
  • Cepheid Inc.
  • DAAN Gene Co. Ltd.
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • Grifols SA
  • Guangzhou Wondfo Biotech Co Ltd
  • Hologic Inc.
  • Illumina Inc.
  • Meril Life Sciences Pvt. Ltd.
  • PerkinElmer US LLC
  • QIAGEN N.V.
  • QuidelOrtho Corp.
  • Randox Laboratories Ltd.
  • Shenzhen Mindray Co. Ltd.
  • Siemens Healthineers AG
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.
  • Werfenlife SA

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in In-vitro diagnostics instruments market

  • In the Health Care Equipment industry, the implementation of the European In Vitro Diagnostic Regulation mandated exhaustive technical documentation and clinical evidence protocols, directly impacting In-vitro Diagnostics Instruments demand by accelerating the retirement of legacy systems lacking comprehensive compliance data.
  • The widespread adoption of cloud-connected data reporting standards within hospital infrastructure established secure frameworks for real-time patient monitoring, increasing the requirement for decentralized In-vitro Diagnostics Instruments capable of seamless electronic health record interoperability.
  • The shift toward personalized precision oncology increased the structural necessity for high-throughput assay multiplexing technologies, directly driving adoption rates for advanced In-vitro Diagnostics Instruments by 22% in specialized academic and research institutes.
  • Stringent environmental sustainability regulations concerning hazardous chemical waste management in medical facilities forced a transition toward microfluidic biosensors, pulling demand for eco-friendly In-vitro Diagnostics Instruments that reduce reagent consumption and lower operational disposal costs.

Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled In-Vitro Diagnostics Instruments Market insights. See full methodology.

Market Scope
Page number 320
Base year 2025
Historic period 2020-2024
Forecast period 2026-2030
Growth momentum & CAGR Accelerate at a CAGR of 10%
Market growth 2026-2030 USD 67717.4 million
Market structure Fragmented
YoY growth 2025-2026(%) 9.1%
Key countries US, Canada, Mexico, Germany, UK, France, Italy, Spain, The Netherlands, China, Japan, India, South Korea, Indonesia, Thailand, Brazil, Saudi Arabia, UAE, Turkey, Argentina, Israel, Colombia and South Africa
Competitive landscape Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Request Free Sample

Research Analyst Overview

  • The continuous evolution of In-vitro Diagnostics Instruments is fundamentally reshaping institutional procurement strategies and clinical laboratory workflows. Healthcare administrations are increasingly abandoning outright capital purchases in favor of flexible reagent rental agreements, shifting financial risk while ensuring access to state-of-the-art diagnostic hardware.
  • This budgeting strategy directly supports the rapid integration of complex syndromic testing panels, which empower clinicians to simultaneously evaluate multiple pathogens from a single specimen. The operational deployment of advanced digital polymerase chain reaction systems and automated immunohistochemistry slide stainers has drastically improved oncology diagnostics and companion diagnostic validation.
  • By leveraging these high-precision instruments for circulating tumor dna isolation, modern laboratories have achieved a 28% increase in early-stage biomarker detection and minimal residual disease monitoring compared to traditional biopsy methodologies. Furthermore, the integration of intelligent antimicrobial susceptibility testing platforms allows specialized facilities to combat drug-resistant pathogens with unprecedented speed.
  • As decentralized healthcare models gain traction, the distribution of disposable point-of-care testing cartridges is actively decentralizing the diagnostic supply chain, optimizing long-term therapeutic outcomes.

What are the Key Data Covered in this In-Vitro Diagnostics Instruments Market Research and Growth Report?

  • What is the expected growth of the In-Vitro Diagnostics Instruments Market between 2026 and 2030?

    • USD 67.72 billion, at a CAGR of 10%

  • What segmentation does the market report cover?

    • The report is segmented by Product (Immunochemistry, Clinical microbiology, Molecular diagnostics, and Others), End-user (Hospitals and diagnostic laboratories, Academic and research institutes, and Home care), Application (Infectious diseases, Oncology, Diabetes, Cardiology, and Others) and Geography (North America, Europe, Asia, Rest of World (ROW))

  • Which regions are analyzed in the report?

    • North America, Europe, Asia and Rest of World (ROW)

  • What are the key growth drivers and market challenges?

    • Rising prevalence of chronic and infectious diseases globally, Stringent and evolving regulatory compliance frameworks

  • Who are the major players in the In-Vitro Diagnostics Instruments Market?

    • Abbott Laboratories, Agilent Technologies Inc., Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., BioMerieux SA, Cepheid Inc., DAAN Gene Co. Ltd., DiaSorin SpA, F. Hoffmann La Roche Ltd., Grifols SA, Guangzhou Wondfo Biotech Co Ltd, Hologic Inc., Illumina Inc., Meril Life Sciences Pvt. Ltd., PerkinElmer US LLC, QIAGEN N.V., QuidelOrtho Corp., Randox Laboratories Ltd., Shenzhen Mindray Co. Ltd., Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc. and Werfenlife SA

Market Research Insights

  • The In-vitro Diagnostics Instruments sector represents a critical technological nexus within modern clinical pathology, facilitating high-fidelity biological analysis. Advanced diagnostic facilities are increasingly deploying multi-omics instrumentation to consolidate disjointed testing protocols into unified platforms. By utilizing intelligent pre-analytical error detection algorithms, high-volume reference laboratories have successfully reduced specimen rejection rates by 25% and improved overall processing efficiency by 18%.
  • Furthermore, the integration of automated cellular morphology analysis has enhanced diagnostic consistency in hematological assessments, cutting manual slide review dependencies by 30%. These operational upgrades are essential for optimizing anticoagulant therapy management and accelerating throughput within biomarker discovery platforms. Ultimately, this technological convergence maximizes resource allocation and ensures superior analytical accuracy across complex medical screening environments.

We can help! Our analysts can customize this in-vitro diagnostics instruments market research report to meet your requirements.

Get in touch

1. Executive Summary

1.1 Market overview

Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2. Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

2.2 Criticality of inputs and Factors of differentiation

Chart on Overview on criticality of inputs and factors of differentiation

2.3 Factors of disruption

Chart on Overview on factors of disruption

2.4 Impact of drivers and challenges

Chart on Impact of drivers and challenges in 2025 and 2030

3. Market Landscape

3.1 Market ecosystem

Chart on Parent Market
Data Table on - Parent Market

3.2 Market characteristics

Chart on Market characteristics analysis

3.3 Value chain analysis

Chart on Value chain analysis

4. Market Sizing

4.1 Market definition

Data Table on Offerings of companies included in the market definition

4.2 Market segment analysis

Market segments

4.3 Market size 2025

4.4 Market outlook: Forecast for 2025-2030

Chart on Global - Market size and forecast 2025-2030 ($ million)
Data Table on Global - Market size and forecast 2025-2030 ($ million)
Chart on Global Market: Year-over-year growth 2025-2030 (%)
Data Table on Global Market: Year-over-year growth 2025-2030 (%)

5. Historic Market Size

5.1 Global In-Vitro Diagnostics Instruments Market 2020 - 2024

Historic Market Size - Data Table on Global In-Vitro Diagnostics Instruments Market 2020 - 2024 ($ million)

5.2 Product segment analysis 2020 - 2024

Historic Market Size - Product Segment 2020 - 2024 ($ million)

5.3 End-user segment analysis 2020 - 2024

Historic Market Size - End-user Segment 2020 - 2024 ($ million)

5.4 Application segment analysis 2020 - 2024

Historic Market Size - Application Segment 2020 - 2024 ($ million)

5.5 Geography segment analysis 2020 - 2024

Historic Market Size - Geography Segment 2020 - 2024 ($ million)

5.6 Country segment analysis 2020 - 2024

Historic Market Size - Country Segment 2020 - 2024 ($ million)

6. Qualitative Analysis

6.1 Impact of AI on global in-vitro diagnostics instruments market

6.2 Impact of geopolitical conflicts on global in-vitro diagnostics instruments market

7. Five Forces Analysis

7.1 Five forces summary

Five forces analysis - Comparison between 2025 and 2030

7.2 Bargaining power of buyers

Bargaining power of buyers - Impact of key factors 2025 and 2030

7.3 Bargaining power of suppliers

Bargaining power of suppliers - Impact of key factors in 2025 and 2030

7.4 Threat of new entrants

Threat of new entrants - Impact of key factors in 2025 and 2030

7.5 Threat of substitutes

Threat of substitutes - Impact of key factors in 2025 and 2030

7.6 Threat of rivalry

Threat of rivalry - Impact of key factors in 2025 and 2030

7.7 Market condition

Chart on Market condition - Five forces 2025 and 2030

8. Market Segmentation by Product

8.1 Market segments

Chart on Product - Market share 2025-2030 (%)
Data Table on Product - Market share 2025-2030 (%)

8.2 Comparison by Product

Chart on Comparison by Product
Data Table on Comparison by Product

8.3 Immunochemistry - Market size and forecast 2025-2030

Chart on Immunochemistry - Market size and forecast 2025-2030 ($ million)
Data Table on Immunochemistry - Market size and forecast 2025-2030 ($ million)
Chart on Immunochemistry - Year-over-year growth 2025-2030 (%)
Data Table on Immunochemistry - Year-over-year growth 2025-2030 (%)

8.4 Clinical microbiology - Market size and forecast 2025-2030

Chart on Clinical microbiology - Market size and forecast 2025-2030 ($ million)
Data Table on Clinical microbiology - Market size and forecast 2025-2030 ($ million)
Chart on Clinical microbiology - Year-over-year growth 2025-2030 (%)
Data Table on Clinical microbiology - Year-over-year growth 2025-2030 (%)

8.5 Molecular diagnostics - Market size and forecast 2025-2030

Chart on Molecular diagnostics - Market size and forecast 2025-2030 ($ million)
Data Table on Molecular diagnostics - Market size and forecast 2025-2030 ($ million)
Chart on Molecular diagnostics - Year-over-year growth 2025-2030 (%)
Data Table on Molecular diagnostics - Year-over-year growth 2025-2030 (%)

8.6 Others - Market size and forecast 2025-2030

Chart on Others - Market size and forecast 2025-2030 ($ million)
Data Table on Others - Market size and forecast 2025-2030 ($ million)
Chart on Others - Year-over-year growth 2025-2030 (%)
Data Table on Others - Year-over-year growth 2025-2030 (%)

8.7 Market opportunity by Product

Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)

9. Market Segmentation by End-user

9.1 Market segments

Chart on End-user - Market share 2025-2030 (%)
Data Table on End-user - Market share 2025-2030 (%)

9.2 Comparison by End-user

Chart on Comparison by End-user
Data Table on Comparison by End-user

9.3 Hospitals and diagnostic laboratories - Market size and forecast 2025-2030

Chart on Hospitals and diagnostic laboratories - Market size and forecast 2025-2030 ($ million)
Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2025-2030 ($ million)
Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2025-2030 (%)
Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2025-2030 (%)

9.4 Academic and research institutes - Market size and forecast 2025-2030

Chart on Academic and research institutes - Market size and forecast 2025-2030 ($ million)
Data Table on Academic and research institutes - Market size and forecast 2025-2030 ($ million)
Chart on Academic and research institutes - Year-over-year growth 2025-2030 (%)
Data Table on Academic and research institutes - Year-over-year growth 2025-2030 (%)

9.5 Home care - Market size and forecast 2025-2030

Chart on Home care - Market size and forecast 2025-2030 ($ million)
Data Table on Home care - Market size and forecast 2025-2030 ($ million)
Chart on Home care - Year-over-year growth 2025-2030 (%)
Data Table on Home care - Year-over-year growth 2025-2030 (%)

9.6 Market opportunity by End-user

Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)

10. Market Segmentation by Application

10.1 Market segments

Chart on Application - Market share 2025-2030 (%)
Data Table on Application - Market share 2025-2030 (%)

10.2 Comparison by Application

Chart on Comparison by Application
Data Table on Comparison by Application

10.3 Infectious diseases - Market size and forecast 2025-2030

Chart on Infectious diseases - Market size and forecast 2025-2030 ($ million)
Data Table on Infectious diseases - Market size and forecast 2025-2030 ($ million)
Chart on Infectious diseases - Year-over-year growth 2025-2030 (%)
Data Table on Infectious diseases - Year-over-year growth 2025-2030 (%)

10.4 Oncology - Market size and forecast 2025-2030

Chart on Oncology - Market size and forecast 2025-2030 ($ million)
Data Table on Oncology - Market size and forecast 2025-2030 ($ million)
Chart on Oncology - Year-over-year growth 2025-2030 (%)
Data Table on Oncology - Year-over-year growth 2025-2030 (%)

10.5 Diabetes - Market size and forecast 2025-2030

Chart on Diabetes - Market size and forecast 2025-2030 ($ million)
Data Table on Diabetes - Market size and forecast 2025-2030 ($ million)
Chart on Diabetes - Year-over-year growth 2025-2030 (%)
Data Table on Diabetes - Year-over-year growth 2025-2030 (%)

10.6 Cardiology - Market size and forecast 2025-2030

Chart on Cardiology - Market size and forecast 2025-2030 ($ million)
Data Table on Cardiology - Market size and forecast 2025-2030 ($ million)
Chart on Cardiology - Year-over-year growth 2025-2030 (%)
Data Table on Cardiology - Year-over-year growth 2025-2030 (%)

10.7 Others - Market size and forecast 2025-2030

Chart on Others - Market size and forecast 2025-2030 ($ million)
Data Table on Others - Market size and forecast 2025-2030 ($ million)
Chart on Others - Year-over-year growth 2025-2030 (%)
Data Table on Others - Year-over-year growth 2025-2030 (%)

10.8 Market opportunity by Application

Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)

11. Customer Landscape

11.1 Customer landscape overview

Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12. Geographic Landscape

12.1 Geographic segmentation

Chart on Market share by geography 2025-2030 (%)
Data Table on Market share by geography 2025-2030 (%)

12.2 Geographic comparison

Chart on Geographic comparison
Data Table on Geographic comparison

12.3 North America - Market size and forecast 2025-2030

Chart on North America - Market size and forecast 2025-2030 ($ million)
Data Table on North America - Market size and forecast 2025-2030 ($ million)
Chart on North America - Year-over-year growth 2025-2030 (%)
Data Table on North America - Year-over-year growth 2025-2030 (%)
Chart on Regional Comparison - North America
Data Table on Regional Comparison - North America

12.3.1 US - Market size and forecast 2025-2030

Chart on US - Market size and forecast 2025-2030 ($ million)
Data Table on US - Market size and forecast 2025-2030 ($ million)
Chart on US - Year-over-year growth 2025-2030 (%)
Data Table on US - Year-over-year growth 2025-2030 (%)

12.3.2 Canada - Market size and forecast 2025-2030

Chart on Canada - Market size and forecast 2025-2030 ($ million)
Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Chart on Canada - Year-over-year growth 2025-2030 (%)
Data Table on Canada - Year-over-year growth 2025-2030 (%)

12.3.3 Mexico - Market size and forecast 2025-2030

Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Chart on Mexico - Year-over-year growth 2025-2030 (%)
Data Table on Mexico - Year-over-year growth 2025-2030 (%)

12.4 Europe - Market size and forecast 2025-2030

Chart on Europe - Market size and forecast 2025-2030 ($ million)
Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Chart on Europe - Year-over-year growth 2025-2030 (%)
Data Table on Europe - Year-over-year growth 2025-2030 (%)
Chart on Regional Comparison - Europe
Data Table on Regional Comparison - Europe

12.4.1 Germany - Market size and forecast 2025-2030

Chart on Germany - Market size and forecast 2025-2030 ($ million)
Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Chart on Germany - Year-over-year growth 2025-2030 (%)
Data Table on Germany - Year-over-year growth 2025-2030 (%)

12.4.2 UK - Market size and forecast 2025-2030

Chart on UK - Market size and forecast 2025-2030 ($ million)
Data Table on UK - Market size and forecast 2025-2030 ($ million)
Chart on UK - Year-over-year growth 2025-2030 (%)
Data Table on UK - Year-over-year growth 2025-2030 (%)

12.4.3 France - Market size and forecast 2025-2030

Chart on France - Market size and forecast 2025-2030 ($ million)
Data Table on France - Market size and forecast 2025-2030 ($ million)
Chart on France - Year-over-year growth 2025-2030 (%)
Data Table on France - Year-over-year growth 2025-2030 (%)

12.4.4 Italy - Market size and forecast 2025-2030

Chart on Italy - Market size and forecast 2025-2030 ($ million)
Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Chart on Italy - Year-over-year growth 2025-2030 (%)
Data Table on Italy - Year-over-year growth 2025-2030 (%)

12.4.5 Spain - Market size and forecast 2025-2030

Chart on Spain - Market size and forecast 2025-2030 ($ million)
Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Chart on Spain - Year-over-year growth 2025-2030 (%)
Data Table on Spain - Year-over-year growth 2025-2030 (%)

12.4.6 The Netherlands - Market size and forecast 2025-2030

Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)

12.5 Asia - Market size and forecast 2025-2030

Chart on Asia - Market size and forecast 2025-2030 ($ million)
Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Chart on Asia - Year-over-year growth 2025-2030 (%)
Data Table on Asia - Year-over-year growth 2025-2030 (%)
Chart on Regional Comparison - Asia
Data Table on Regional Comparison - Asia

12.5.1 China - Market size and forecast 2025-2030

Chart on China - Market size and forecast 2025-2030 ($ million)
Data Table on China - Market size and forecast 2025-2030 ($ million)
Chart on China - Year-over-year growth 2025-2030 (%)
Data Table on China - Year-over-year growth 2025-2030 (%)

12.5.2 Japan - Market size and forecast 2025-2030

Chart on Japan - Market size and forecast 2025-2030 ($ million)
Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Chart on Japan - Year-over-year growth 2025-2030 (%)
Data Table on Japan - Year-over-year growth 2025-2030 (%)

12.5.3 India - Market size and forecast 2025-2030

Chart on India - Market size and forecast 2025-2030 ($ million)
Data Table on India - Market size and forecast 2025-2030 ($ million)
Chart on India - Year-over-year growth 2025-2030 (%)
Data Table on India - Year-over-year growth 2025-2030 (%)

12.5.4 South Korea - Market size and forecast 2025-2030

Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Chart on South Korea - Year-over-year growth 2025-2030 (%)
Data Table on South Korea - Year-over-year growth 2025-2030 (%)

12.5.5 Indonesia - Market size and forecast 2025-2030

Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Data Table on Indonesia - Year-over-year growth 2025-2030 (%)

12.5.6 Thailand - Market size and forecast 2025-2030

Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Chart on Thailand - Year-over-year growth 2025-2030 (%)
Data Table on Thailand - Year-over-year growth 2025-2030 (%)

12.6 Rest of World (ROW) - Market size and forecast 2025-2030

Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Chart on Regional Comparison - Rest of World (ROW)
Data Table on Regional Comparison - Rest of World (ROW)

12.6.1 Brazil - Market size and forecast 2025-2030

Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Chart on Brazil - Year-over-year growth 2025-2030 (%)
Data Table on Brazil - Year-over-year growth 2025-2030 (%)

12.6.2 Saudi Arabia - Market size and forecast 2025-2030

Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)

12.6.3 UAE - Market size and forecast 2025-2030

Chart on UAE - Market size and forecast 2025-2030 ($ million)
Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Chart on UAE - Year-over-year growth 2025-2030 (%)
Data Table on UAE - Year-over-year growth 2025-2030 (%)

12.6.4 Turkey - Market size and forecast 2025-2030

Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Chart on Turkey - Year-over-year growth 2025-2030 (%)
Data Table on Turkey - Year-over-year growth 2025-2030 (%)

12.6.5 Argentina - Market size and forecast 2025-2030

Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Chart on Argentina - Year-over-year growth 2025-2030 (%)
Data Table on Argentina - Year-over-year growth 2025-2030 (%)

12.6.6 Israel - Market size and forecast 2025-2030

Chart on Israel - Market size and forecast 2025-2030 ($ million)
Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Chart on Israel - Year-over-year growth 2025-2030 (%)
Data Table on Israel - Year-over-year growth 2025-2030 (%)

12.6.7 Colombia - Market size and forecast 2025-2030

Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Chart on Colombia - Year-over-year growth 2025-2030 (%)
Data Table on Colombia - Year-over-year growth 2025-2030 (%)

12.6.8 South Africa - Market size and forecast 2025-2030

Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Chart on South Africa - Year-over-year growth 2025-2030 (%)
Data Table on South Africa - Year-over-year growth 2025-2030 (%)

12.7 Market opportunity by geography

Market opportunity by geography ($ million)
Data Tables on Market opportunity by geography ($ million)

13. Drivers, Challenges, and Opportunity

13.1 Market drivers

Rising prevalence of chronic and infectious diseases globally
Technological advancements in laboratory automation and AI
Product launchesaEscalating demand for point-of-care testing and decentralized diagnostics

13.2 Market challenges

Stringent and evolving regulatory compliance frameworks
Severe shortages of skilled laboratory personnel and specialized technicians
High capital expenditures and operational costs of advanced instrumentation

13.3 Impact of drivers and challenges

Impact of drivers and challenges in 2025 and 2030

13.4 Market opportunities

Accelerated shift toward laboratory automation and AI integration
Expansion of high precision decentralized diagnostics
Rising dominance of molecular diagnostics and precision oncology applications

14. Competitive Landscape

14.1 Overview

14.2

Overview on criticality of inputs and factors of differentiation

14.3 Landscape disruption

Overview on factors of disruption

14.4 Industry risks

Impact of key risks on business

15. Competitive Analysis

15.1 Companies profiled

Companies covered

15.2 Company ranking index

15.3 Market positioning of companies

Matrix on companies position and classification

15.4 Abbott Laboratories

Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
SWOT

15.5 Agilent Technologies Inc.

Agilent Technologies Inc. - Overview
Agilent Technologies Inc. - Business segments
Agilent Technologies Inc. - Key news
Agilent Technologies Inc. - Key offerings
Agilent Technologies Inc. - Segment focus
SWOT

15.6 Becton Dickinson and Co.

Becton Dickinson and Co. - Overview
Becton Dickinson and Co. - Business segments
Becton Dickinson and Co. - Key offerings
Becton Dickinson and Co. - Segment focus
SWOT

15.7 Bio Rad Laboratories Inc.

Bio Rad Laboratories Inc. - Overview
Bio Rad Laboratories Inc. - Business segments
Bio Rad Laboratories Inc. - Key news
Bio Rad Laboratories Inc. - Key offerings
Bio Rad Laboratories Inc. - Segment focus
SWOT

15.8 BioMerieux SA

BioMerieux SA - Overview
BioMerieux SA - Business segments
BioMerieux SA - Key offerings
BioMerieux SA - Segment focus
SWOT

15.9 DAAN Gene Co. Ltd.

DAAN Gene Co. Ltd. - Overview
DAAN Gene Co. Ltd. - Product / Service
DAAN Gene Co. Ltd. - Key offerings
SWOT

15.10 DiaSorin SpA

DiaSorin SpA - Overview
DiaSorin SpA - Business segments
DiaSorin SpA - Key offerings
DiaSorin SpA - Segment focus
SWOT

15.11 F. Hoffmann La Roche Ltd.

F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT

15.12 PerkinElmer US LLC

PerkinElmer US LLC - Overview
PerkinElmer US LLC - Product / Service
PerkinElmer US LLC - Key offerings
SWOT

15.13 QIAGEN N.V.

QIAGEN N.V. - Overview
QIAGEN N.V. - Product / Service
QIAGEN N.V. - Key offerings
SWOT

15.14 QuidelOrtho Corp.

QuidelOrtho Corp. - Overview
QuidelOrtho Corp. - Business segments
QuidelOrtho Corp. - Key offerings
QuidelOrtho Corp. - Segment focus
SWOT

15.15 Shenzhen Mindray Co. Ltd.

Shenzhen Mindray Co. Ltd. - Overview
Shenzhen Mindray Co. Ltd. - Business segments
Shenzhen Mindray Co. Ltd. - Key offerings
Shenzhen Mindray Co. Ltd. - Segment focus
SWOT

15.16 Siemens Healthineers AG

Siemens Healthineers AG - Overview
Siemens Healthineers AG - Business segments
Siemens Healthineers AG - Key offerings
Siemens Healthineers AG - Segment focus
SWOT

15.17 Sysmex Corp.

Sysmex Corp. - Overview
Sysmex Corp. - Business segments
Sysmex Corp. - Key news
Sysmex Corp. - Key offerings
Sysmex Corp. - Segment focus
SWOT

15.18 Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
SWOT

16. Appendix

16.1 Scope of the report

Market definition
Objectives
Notes and caveats

16.2 Inclusions and exclusions checklist

Inclusions checklist
Exclusions checklist

16.3 Currency conversion rates for US$

16.4 Research methodology

16.5 Data procurement

Information sources

16.6 Data validation

16.7 Validation techniques employed for market sizing

16.8 Data synthesis

16.9 360 degree market analysis

16.10 List of abbreviations

Research Methodology

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

Interested in this report?

Get your sample now to see our research methodology and insights!

Download Now

Frequently Asked Questions

In-Vitro Diagnostics Instruments market growth will increase by USD 67717.4 million during 2026-2030.

The In-Vitro Diagnostics Instruments market is expected to grow at a CAGR of 10% during 2026-2030.

In-Vitro Diagnostics Instruments market is segmented by Product (Immunochemistry, Clinical microbiology, Molecular diagnostics, Others) End-user (Hospitals and diagnostic laboratories, Academic and research institutes, Home care) Application (Infectious diseases, Oncology, Diabetes, Cardiology, Others)

Abbott Laboratories, Agilent Technologies Inc., Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., BioMerieux SA, Cepheid Inc., DAAN Gene Co. Ltd., DiaSorin SpA, F. Hoffmann La Roche Ltd., Grifols SA, Guangzhou Wondfo Biotech Co Ltd, Hologic Inc., Illumina Inc., Meril Life Sciences Pvt. Ltd., PerkinElmer US LLC, QIAGEN N.V., QuidelOrtho Corp., Randox Laboratories Ltd., Shenzhen Mindray Co. Ltd., Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc., Werfenlife SA are a few of the key vendors in the In-Vitro Diagnostics Instruments market.

Asia will register the highest growth rate of 31.9% among the other regions. Therefore, the In-Vitro Diagnostics Instruments market in Asia is expected to garner significant business opportunities for the vendors during the forecast period.

US, Canada, Mexico, Germany, UK, France, Italy, Spain, The Netherlands, China, Japan, India, South Korea, Indonesia, Thailand, Brazil, Saudi Arabia, UAE, Turkey, Argentina, Israel, Colombia, South Africa

  • Rising prevalence of chronic and infectious diseases globally is the driving factor this market.

The In-Vitro Diagnostics Instruments market vendors should focus on grabbing business opportunities from the Product segment as it accounted for the largest market share in the base year.
RIA - Research AI Assistant
Ask RIA